The number of FDA approved drugs per billion US
dollars of R&D spend has halved every 9 years
Success rates for new products in early
development has fallen from 28% to 18%
Insufficient efficacy is the most frequent reason
for early stage drug development failure
But fear not! Exploratory Clinical Development World Europe will help
you plan and implement the right strategy to bridge the translational
gap. It will provide you with the latest approaches and strategies to
extrapolate results allowing you to take the best candidate forwards.
